EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?

Catia Marzolini iD, Saye Khoo

British Journal of Clinical Pharmacology · 30.10.2026

DOI: 10.1002/bcp.70900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 30.10.2026. Verfasst von Catia Marzolini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Service of Clinical Pharmacology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Service of Clinical Pharmacology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland.
  • Division of Infectious Diseases, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Centre for Experimental Therapeutics, University of Liverpool, Liverpool, UK.

ORCID-Profile: Catia Marzolini

Zitieren

APA

Marzolini, C., & Khoo, S. (2026). Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70900

Vancouver

Marzolini C, Khoo S. Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70900

BibTeX
@article{Marzolini2026,
  author = {Marzolini, Catia and Khoo, Saye},
  title = {Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70900}
}
Kostenlos starten →